UK markets closed

Altamira Therapeutics Ltd. (CYTO)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.4500-0.0300 (-2.03%)
At close: 04:00PM EDT
1.3700 -0.08 (-5.52%)
After hours: 07:38PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in CHF. All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Cost of revenue
-
-
1,444
2,241
0
Gross profit
-
-
-1,138
-2,177
0
Operating expenses
Research development
3,035
3,035
14,622
3,203
2,863
Selling general and administrative
3,004
3,004
3,280
3,638
2,595
Total operating expenses
5,916
5,916
18,014
6,871
5,283
Operating income or loss
-5,916
-5,916
-18,014
-6,871
-5,283
Interest expense
1,032
1,032
904.345
14.112
135.151
Total other income/expenses net
-623.744
-623.744
145.571
52.246
-2,803
Income before tax
-7,270
-7,270
-18,660
-6,806
-8,221
Income tax expense
0
0
-7.919
-117.945
-21.284
Income from continuing operations
-7,270
-7,270
-18,652
-6,688
-8,200
Net income
-3,869
-3,869
-26,528
-17,058
-8,200
Net income available to common shareholders
-3,869
-3,869
-26,528
-17,058
-8,200
Basic EPS
-395.80
-7.88
-582.58
-515.11
-505.40
Diluted EPS
-395.80
-7.88
-582.58
-515.11
-505.40
Basic average shares
131.141
491.258
45.536
33.116
15.035
Diluted average shares
131.141
491.258
45.536
33.116
15.035